Innar Tõru, Anu Aluoja, Ulle Võhma, Mait Raag, Veiko Vasar, Eduard Maron, Jakov Shlik
Index: Psychiatry Res. 178(2) , 342-7, (2010)
Full Text: HTML
In this study we examined how personality disposition may affect the response to cholecystokinin tetrapeptide (CCK-4; 50 microg) challenge in healthy volunteers (n=105). Personality traits were assessed with the Swedish universities Scales of Personality (SSP). Statistical methods employed were correlation analysis and logistic regression. The results showed that the occurrence of CCK-4-induced panic attacks was best predicted by baseline diastolic blood pressure, preceding anxiety and SSP-defined traits of lack of assertiveness, detachment, embitterment and verbal aggression. Significant interactions were noted between the above mentioned variables, modifying their individual effects. For different subsets of CCK-4-induced symptoms, the traits of physical aggression, irritability, somatic anxiety and stress susceptibility also appeared related to panic manifestations. These findings suggest that some personality traits and their interactions may influence vulnerability to CCK-4-induced panic attacks in healthy volunteers.Copyright 2010 Elsevier Ireland Ltd. All rights reserved.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
CCK-4
CAS:1947-37-1 |
C29H36N6O6S |
Overexpression of the Promigratory and Prometastatic PTK7 Re...
2015-01-01 [PLoS ONE 10 , e0123768, (2015)] |
CI-988 Inhibits EGFR Transactivation and Proliferation Cause...
2015-07-01 [J. Mol. Neurosci. 56 , 663-72, (2015)] |
Synthesis, characterization and in vitro evaluation of new o...
2010-02-01 [Eur. J. Med. Chem. 45(2) , 423-9, (2010)] |
[Effect of GB-115 dipeptide on anxiety in rats with model be...
2011-01-01 [Eksp. Klin. Farmakol. 74(10) , 7-11, (2011)] |
Solid-phase extraction-field-amplified sample injection coup...
2011-10-01 [Electrophoresis 32(20) , 2823-9, (2011)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved